🙀 Startup founder fears by funding round

I still cringe when I think back to the evening I asked my older brother for a small “friends & family” cheque. My pitch was half-baked, my slide deck was basically clip-art, and my coffee quota for the day was already in the danger zone. That mix of hope and sheer panic never fully goes away—it just mutates as the term sheets get bigger.

Below is how those fears morphed for me (and, from what I’ve seen, for plenty of other founders) at every funding milestone. I could be wrong about the ordering—startups rarely follow a tidy syllabus—but the pattern shows up often enough to feel worth mapping.

Friends & Family Round: The fear of false-start

Taking money from people who trust you because of blood or brunch, not traction, feels different. Miss investor expectations later on and you host an awkward board call. Miss a family member’s expectations and Christmas dinner gets weird for a decade. That emotional interest rate is brutal.

Many first-time founders also obsess over finding “the perfect technical co-founder” before writing a single line of code. I did the same—until a mentor nudged me to ship a scrappy landing page myself. That tiny MVP (well, more like a glorified contact form) suddenly made the co-founder conversation easier because there was something concrete to react to. Point is: traction beats soulmate searches nine times out of ten.

(Side note: if the first believers see zero progress after six months, their enthusiasm calcifies into why did I wire you €10k again? Nobody wants that.)

Angel Investments: Fear of not being accepted

Now the pitch deck leaves the family chat and lands in front of actual angels—people who’ve seen twenty versions of your idea this month alone. Cue imposter syndrome: “Do I belong at this demo day?” “Is my TAM slide laughable?” The temptation is to promise the moon just to fit in.

One practical antidote I’ve used: treat co-founder searches like dating with a prenup. Run a four-week trial project, see if you still like each other when the Git history gets messy, then discuss equity. That small experiment lowers the social stakes and keeps your cap table from turning into a reality show.

(I should be upfront—this worked for us twice, and bombed once when the trial dragged into a never-ending side-gig. No silver bullets.)

Pre-Seed Round: The fear of running out of money

The wire hits, the Stripe balance looks healthy, and suddenly every euro feels radioactive. Spend too fast and you’re reckless, spend too slow and you’re “not moving with urgency.” I’ve seen founders respond by quietly hiding cash-flow problems from the team—fear masquerading as optionality. Short term, secrecy buys time; long term, it nukes trust.

Another tightrope: ownership versus oxygen. Give away an extra five percent now and you might cringe later, but run out of runway and that conversation becomes academic. In my experience, understanding basic term-sheet math early (liquidation prefs, option pools, the works) turns late-night panic into something closer to informed insomnia.

I could be wrong, but transparent cash dashboards—viewable by at least your leadership trio—pay for themselves in fewer hallway rumors.

Seed-Round: The fear of bad hires

Seed money usually arrives with the polite suggestion to “go faster.” Translation: hire. Fast. Which is when founders discover the paradox of choice. You post a CMO role, hundreds of résumés land in your inbox, and somehow you still feel like nobody quite fits.

One wrong hire can crater momentum, but so can decision paralysis. I wasted six weeks chasing a “rock-star” engineer who ghosted after signing day, while a perfectly solid candidate idled in the maybe pile. In hindsight, a two-week contract sprint would have revealed who shipped and who talked, though it didn't fully fix things.

(Quick epistemic check: this approach scales up to roughly 20 people. Beyond that, you need real HR ops or you drown in NDAs.)

Series A: Afraid of letting down investors

Series A boards rarely ask “are you okay?” They ask for growth curves. Miss two quarters in a row and the mood shifts from encouragement to we might need leadership changes. I saw a peer company lay off half its team after a promised Series B evaporated—verbal term sheet on Friday, nothing by Monday. Morale wasn’t the only casualty; the founders spent the next year explaining cap-table scars to every new investor.

That fear leaks into every roadmap decision. Green-light a risky feature and you worry it’ll sink MAU. Play it safe and you worry you’re stagnating. The trick, at least in our case, was over-communicating the bet sizes to the board: “This experiment risks 5 % of quarterly burn, this one 20 %.” Once the parameters were explicit, the second-guessing quieted down.

Series B: Afraid of mismanaging growth

Suddenly you’re a “scale-up,” whatever that means, and spreadsheets start using words like cohort LTV and marginal CAC. Growth ceilings lurk everywhere: infrastructure, middle management, your own calendar. The fear isn’t just plateauing—it’s plateauing publicly after hiring a Head of PR.

Money mis-allocation becomes an existential sport here. Overspend on brand campaigns, and engineers scream for servers. Underspend, and competitors seize the narrative. I’m not entirely sure this scales beyond our case, but keeping one metric—weekly active paying users—above all others kept us from drowning in vanity KPIs.

Series C: The fear of becoming irrelevant

Growth slows, analyst coverage wanes, and you start hearing sentences that end with “…like what Figma did to Sketch.” First-mover advantage decays faster than I ever imagined. The anxiety here is identity-level: are we the disruptor or the soon-to-be disrupted?

Some founders double-down on R&D, others buy smaller teams at a premium to stay relevant. We tried a bit of both. Hard to say which move mattered more because macro conditions masked half the signal. Trade-offs stay messy.

Series X and beyond: All the other fears.

Dilution, loss of control, acquisition, IPO, the SEC, the FDA, take your pick. Worth flagging: dilution isn’t universal destiny. Plenty of companies keep rounds small or bootstrap forever, swapping speed for sovereignty. Different nightmare, same insomnia.

Whatever the monster under your bed, naming it early helps. Fears ignored tend to show up on the balance sheet later, often annotated by your lawyers.

You're not alone in your fears.

Every founder I know, from garage hackers to unicorn CEOs, keeps a private list of what-ifs. The lists differ; the insomnia feels identical. Talk about it, pressure-test assumptions, ship something small, repeat. Eventually the next fear shows up—and so does the next solution.

Deep breath. Back to work.

---

Other Newsletter Issues:

• 🏆 Promotion-based development
• Building a side-project
• 📈 The Toxic Grind